Treatment with Resv or ET was associated with a reduction in 25 kDa molecular weight of Aβ detected by 4G8 and 65 kDa protein detected by BACE-1 antibodies compared to 3xTg-AD mice (Figure 3a). Here, BACE1 is linked to Alzheimer disease.